U.S. Cellular [USM] vs Frontier [FYBR] Detailed Stock Comparison
U.S. Cellular
NYSE
Loading...
Frontier
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: U.S. Cellular wins in 9 metrics, Frontier wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | U.S. Cellular | Frontier | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 74.34 | 262.45 | U.S. Cellular |
| Price-to-Book Ratio | 1.44 | 1.95 | U.S. Cellular |
| Debt-to-Equity Ratio | 82.27 | 249.32 | U.S. Cellular |
| PEG Ratio | 0.87 | -54.60 | Frontier |
| EV/EBITDA | 12.89 | 9.58 | Frontier |
| Profit Margin (TTM) | -0.65% | -6.40% | U.S. Cellular |
| Operating Margin (TTM) | 3.60% | 4.22% | Frontier |
| EBITDA Margin (TTM) | 3.60% | 4.22% | Frontier |
| Return on Equity | -0.47% | -7.82% | U.S. Cellular |
| Return on Assets (TTM) | 0.68% | 1.28% | Frontier |
| Free Cash Flow (TTM) | $326.00M | $-1.16B | U.S. Cellular |
| 1-Year Return | 0.78% | 28.90% | Frontier |
| Price-to-Sales Ratio (TTM) | 1.79 | 1.54 | Frontier |
| Enterprise Value | $9.99B | $20.75B | Frontier |
| EV/Revenue Ratio | 2.70 | 3.43 | U.S. Cellular |
| Gross Profit Margin (TTM) | 57.21% | 65.05% | Frontier |
| Revenue per Share (TTM) | $43 | $24 | U.S. Cellular |
| Earnings per Share (Diluted) | $-0.29 | $-1.56 | U.S. Cellular |
| Beta (Stock Volatility) | N/A | 0.96 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
U.S. Cellular vs Frontier Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| U.S. Cellular | 4.04% | -26.63% | -20.07% | -7.83% | -14.66% | -11.86% |
| Frontier | -0.16% | -0.51% | -0.27% | 0.33% | 3.10% | 5.91% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| U.S. Cellular | 0.78% | 87.54% | 52.29% | 50.93% | 28.70% | 4.36% |
| Frontier | 28.90% | 38.79% | 42.38% | 42.38% | 42.38% | 42.38% |
Performance & Financial Health Analysis: U.S. Cellular vs Frontier
| Metric | USM | FYBR |
|---|---|---|
| Market Information | ||
| Market Cap | $6.62B | $9.29B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 577,961 | 2,922,541 |
| 90 Day Avg. Volume | 434,127 | 2,763,900 |
| Last Close | $55.83 | $36.89 |
| 52 Week Range | $50.69 - $79.17 | $27.67 - $39.21 |
| % from 52W High | -29.48% | -5.92% |
| All-Time High | $125.75 (Nov 29, 1999) | $39.21 (Sep 02, 2024) |
| % from All-Time High | -55.60% | -5.92% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.04% |
| Quarterly Earnings Growth | 0.82% | 0.04% |
| Financial Health | ||
| Profit Margin (TTM) | -0.01% | -0.06% |
| Operating Margin (TTM) | 0.04% | 0.04% |
| Return on Equity (TTM) | 0.00% | -0.08% |
| Debt to Equity (MRQ) | 82.27 | 249.32 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $53.49 | $19.02 |
| Cash per Share (MRQ) | $4.49 | $1.65 |
| Operating Cash Flow (TTM) | $852.00M | $1.91B |
| Levered Free Cash Flow (TTM) | $227.25M | $-727,875,008 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: U.S. Cellular vs Frontier
| Metric | USM | FYBR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 74.34 | 262.45 |
| Forward P/E | 66.97 | -54.60 |
| PEG Ratio | 0.87 | -54.60 |
| Price to Sales (TTM) | 1.79 | 1.54 |
| Price to Book (MRQ) | 1.44 | 1.95 |
| Market Capitalization | ||
| Market Capitalization | $6.62B | $9.29B |
| Enterprise Value | $9.99B | $20.75B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.70 | 3.43 |
| Enterprise to EBITDA | 12.89 | 9.58 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.96 |
| Book Value per Share (MRQ) | $53.49 | $19.02 |
Financial Statements Comparison: U.S. Cellular vs Frontier
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | USM | FYBR |
|---|---|---|
| Revenue/Sales | $891.00M | $1.52B |
| Cost of Goods Sold | $354.00M | $532.00M |
| Gross Profit | $537.00M | $990.00M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $42.00M | $60.00M |
| EBITDA | $244.00M | $531.00M |
| Pre-Tax Income | $40.00M | $-139.00M |
| Income Tax | $20.00M | $-16.00M |
| Net Income (Profit) | $20.00M | $-123.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | USM | FYBR |
|---|---|---|
| Cash & Equivalents | $182.00M | $506.00M |
| Total Current Assets | $1.37B | $1.08B |
| Total Current Liabilities | $807.00M | $2.60B |
| Long-Term Debt | $3.65B | $11.63B |
| Total Shareholders Equity | $4.62B | $4.88B |
| Retained Earnings | $2.82B | $498.00M |
| Property, Plant & Equipment | $925.00M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | USM | FYBR |
|---|---|---|
| Operating Cash Flow | $126.00M | $497.00M |
| Capital Expenditures | $-72.00M | N/A |
| Free Cash Flow | $86.00M | $-238.00M |
| Debt Repayment | $-5.00M | $-10.00M |
| Common Stock Repurchase | $-21.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | USM | FYBR |
|---|---|---|
| Shares Short | 1.36M | 6.53M |
| Short Ratio | 4.19 | 2.45 |
| Short % of Float | 0.06% | 0.03% |
| Average Daily Volume (10 Day) | 577,961 | 2,922,541 |
| Average Daily Volume (90 Day) | 434,127 | 2,763,900 |
| Shares Outstanding | 85.09M | 249.70M |
| Float Shares | 14.91M | 222.36M |
| % Held by Insiders | 0.74% | 0.01% |
| % Held by Institutions | 0.29% | 0.94% |
Dividend Analysis & Yield Comparison: U.S. Cellular vs Frontier
| Metric | USM | FYBR |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |